Hepatocellular Research Registry
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Vanderbilt University.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Vanderbilt University
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00178893
First received: September 12, 2005
Last updated: August 20, 2010
Last verified: August 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a registry of human hepatocytes (liver cells) for research purposes.
| Condition |
|---|
|
Hepatocytes |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Prospective |
| Official Title: | CellzDirect: Hepatocellular Research Registry |
Further study details as provided by Vanderbilt University:
Biospecimen Retention: Samples Without DNA
Detailed Description:
Hepatocytes
| Estimated Enrollment: | 200 |
| Study Start Date: | April 2004 |
| Estimated Study Completion Date: | December 2012 |
Patients scheduled for partial hepatectomy/liver surgery are asked permission to use their discarded liver tissue for purposes of studying:
- how drugs/medicines affect the liver and
- the effects of storing liver cells in the cold or freezing.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Any patient having liver resection operation.
Criteria
Inclusion Criteria:
- Persons undergoing partial hepatectomy/liver surgery for any reason.
Exclusion Criteria:
- Persons with known HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV)
- A diagnosis of hepatocellular carcinoma without negative serologies
- A diagnosis of cholangiocarcinoma, where the total bilirubin has ever been greater or equal to 3.0
- The presence of a biliary drainage tube
- Active sepsis
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00178893
Contacts
| Contact: Stephanie N Logan, RN, BSN | 615-936-8421 | stephanie.n.logan@Vanderbilt.edu |
Locations
| United States, Tennessee | |
| Vanderbilt University | Recruiting |
| Nashville, Tennessee, United States, 37232-4753 | |
| Contact: Stephanie N Logan, RN, BSN 615-936-8421 stephanie.n.logan@vanderbilt.edu | |
| Principal Investigator: Sunil K Geevarghese, MD, MSCI | |
Sponsors and Collaborators
Vanderbilt University
Investigators
| Principal Investigator: | Sunil K Geevarghese, MD, MSCI | Vanderbilt University |
More Information
No publications provided
| Responsible Party: | Sunil K. Geevarghese. MD, MSCI, Vanderbilt University Medical Center |
| ClinicalTrials.gov Identifier: | NCT00178893 History of Changes |
| Other Study ID Numbers: | 040220 |
| Study First Received: | September 12, 2005 |
| Last Updated: | August 20, 2010 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on May 16, 2013